Hengrui and Kailera report positive phase 3 results for dual GLP-1/GIP agonist in obesity treatment Read more
Emcure Pharmaceuticals and Sanofi India sign exclusive distribution agreement for oral anti-diabetic products in India Read more
Panel Discussion: Future-ready formulations: Addressing the challenges of special populations Read more
Panel Discussion: Topical and transdermal drug delivery: The rise of non-invasive therapies Read more